GoodRx teams with Novo Nordisk to expand access to Ozempic and Wegovy for $499-per-month
Until today, Ozempic has not been available to eligible self-paying patients at this price.
GoodRx
GoodRx research shows 1 in 3 Americans live in a healthcare desert
The report shows how access to health services remains deeply uneven as healthcare systems prepare for cutbacks in federal funding.
GoodRx rolls out new ED subscription service to simplify access and eliminate treatment barriers
The all-in-one solution includes virtual consultation, FDA-approved prescription medication, and discreet home delivery, with no hidden fees, in-person visits, or memberships required.
GoodRx rolls out Community Link to offer independent pharmacies Cost-Plus Pricing
Community Link allows independent pharmacies to direct contract with GoodRx, manage participation in the company’s Integrated Savings Program.
GoodRx unveiling direct contracting for independent community pharmacies
GoodRx is hosting a webinar on June 3 and 4 to discuss how the company is supporting direct contracting with GoodRx.
GoodRx Tracker reveals inflation’s toll on prescriptions and consumer essentials
Prescription medications have seen the highest inflation compared to other medical goods, like nonprescription medications and medical equipment.
New report from GoodRx tracks changes in GLP-1 insurance coverage
In 2025, the number of people without commercial insurance coverage for these medications surged significantly. Zepbound saw a 14% increase since 2024, leaving 4.9 million people without coverage, and Ozempic saw a 22% increase, affecting another 1.1 million people.